Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001470831-26-000883

President, COO & Interim CEO sold 17,500 shares at an average $22.90 ($400,716)

  • President, COO & Interim CEO acquired 17,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohlhepp Ryan President, COO & Interim CEO 2026-09-08 Option exercise 10b5-1 +17,500 $3.79 $66,322 199,141 D
Cohlhepp Ryan President, COO & Interim CEO 2026-09-08 Sale 10b5-1 −14,058 $22.77 $320,053 185,083 D
Cohlhepp Ryan President, COO & Interim CEO 2026-09-08 Sale 10b5-1 −3,442 $23.43 $80,663 181,641 D
Derivatives
Cohlhepp Ryan President, COO & Interim CEO 2026-09-08 Option exercise · Stock Option (Right to Buy) 10b5-1 −17,500 34,252 D
Open-market sales · 17,500 sh · avg $22.90 · $400,716
Loading xslF345X06/wk-form4_1789071782.xml…